Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pathogenesis Pilot Study to Evaluate the Impact of Switching to Tenofovir/lamivudine/doravirine on Adipose Tissue (AT) Morphology and Functions in Suppressed Patients with Weight Gain on an INSTI-based Regimen

NCT05477407 is registered in ClinicalTrials.gov with Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05477407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pathogenesis Pilot Study to Evaluate the Impact of Switching to Tenofovir/lamivudine/doravirine on Adipose Tissue (AT) Morphology and Functions in Suppressed Patients with Weight Gain on an INSTI-based Regimen
Lead sponsor
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Phase
Not applicable
Overall status
Completed
Start date
October 6, 2022
Completion date
January 1, 2025
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.